A bit more
$Senti Biosciences(SNTI.US$ Senti Bio Announces Publication of SENTI-202 Preclinical Data; Says Data Supports The Design Of Phase 1 Clinical Trial With Patient Dosing Anticipated In Q2
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
